Drug in pipeline
From DrugPedia: A Wikipedia for Drug discovery
(Difference between revisions)
| Line 122: | Line 122: | ||
|Bacterial Infection | |Bacterial Infection | ||
|- | |- | ||
| - | + | |Stavzor (valproic acid) | |
| + | | | ||
| + | |Bipolar Disorder | ||
| + | |- | ||
| + | |Asenapine | ||
| + | | | ||
| + | |Bipolar Disorder | ||
| + | |- | ||
| + | |Gepirone ER | ||
| + | | | ||
| + | |Depression | ||
| + | |- | ||
| + | |Galvus (vildagliptin) | ||
| + | | | ||
| + | |Diabetes, Type 2 | ||
| + | |- | ||
| + | |Pargluva (muraglitazar) | ||
| + | | | ||
| + | |Diabetes, Type 2 | ||
| + | |- | ||
| + | |Alogliptin | ||
| + | | | ||
| + | |Diabetes, Type 2 | ||
| + | |- | ||
| + | |Naturlose (tagatose) | ||
| + | | | ||
| + | |Diabetes, Type 2 | ||
| + | |- | ||
| + | |Liraglutide | ||
| + | | | ||
| + | |Diabetes, Type 2 | ||
| + | |- | ||
| + | |Onglyza (saxagliptin) | ||
| + | | | ||
| + | |Diabetes, Type 2 | ||
| + | |- | ||
|} | |} | ||
Revision as of 09:13, 5 September 2008
| Name | Company | Treatment |
|---|---|---|
| Advexin (p53 tumor suppressor therapy) | Introgen Therapeutics, Inc. | Head and Neck Cancer |
| Embeda (morphine extended-release with sequestered naltrexone hydrochloride) | Alpharma Inc. | Pain |
| Onsolis (fentanyl) - formerly BEMA Fentanyl | BioDelivery Sciences International, Inc. | Pain |
| Paliperidone palmitate Intramuscular Injection | Elan Corporation, plc and Johnson & Johnson Pharmaceutical Research & Development, L.L.C | Schizophrenia |
| Kynapid (vernakalant) Intravenous Injection - formerly RSD1235 | Cardiome Pharma Corp. | Atrial Fibrillation |
| Multaq (dronedarone) | Sanofi-aventis | Atrial Fibrillation, Atrial Flutter |
| Ustekinumab | Centocor, Inc. | Psoriasis |
| OT-730 | Othera Pharmaceuticals, Inc. | Glaucoma |
| ATryn (antithrombin alfa) | GTC Biotherapeutics, Inc. | Antithrombin III Deficiency |
| Surfaxin (lucinactant) | Discovery Laboratories, Inc. | Respiratory Distress Syndrome |
| Sugammadex | Schering-Plough Corporation | Reversal of Nondepolarizing Muscle Relaxants |
| Xarelto (rivaroxaban) | Johnson & Johnson Pharmaceutical Research and Development | Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery, Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery |
| Actemra (tocilizumab) | Roche | Rheumatoid Arthritis |
| Vimpat (lacosamide) | UCB | Diabetic Neuropathy, Seizures |
| Sublinox (zolpidem) Sublingual Tablets | Orexo and Meda AB | |
| Iloperidone | Vanda Pharmaceuticals Inc. | Schizophrenia |
| Aquavan (fospropofol disodium) Injection | MGI Pharma, Inc. | Sedation |
| Alprox-TD (alprostadil) Cream | NexMed, Inc. | Erectile Dysfunction |
| Zipsor (diclofenac potassium) | Xanodyne Pharmaceuticals, Inc. | Pain |
| Viread | HIV/AIDS | |
| Emtriva | HIV/AIDS | |
| Velac (clindamycin and tretinoin) | Acne | |
| PW2101 | Angina | |
| Arcoxia (etoricoxib) | Osteoarthritis | |
| Pennsaid (diclofenac sodium) | Osteoarthritis | |
| Prexige (lumiracoxib) | Osteoarthritis | |
| Flutiform (formoterol and fluticasone) | Asthma | |
| Orapem (faropenem medoxomil) | Bacterial Infection | |
| Garenoxacin | Bacterial Infection | |
| Stavzor (valproic acid) | Bipolar Disorder | |
| Asenapine | Bipolar Disorder | |
| Gepirone ER | Depression | |
| Galvus (vildagliptin) | Diabetes, Type 2 | |
| Pargluva (muraglitazar) | Diabetes, Type 2 | |
| Alogliptin | Diabetes, Type 2 | |
| Naturlose (tagatose) | Diabetes, Type 2 | |
| Liraglutide | Diabetes, Type 2 | |
| Onglyza (saxagliptin) | Diabetes, Type 2 |
